Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy.
Adult
Aged
Aged, 80 and over
Biomarkers
/ blood
C-Reactive Protein
/ analysis
Female
Humans
Inflammation
/ blood
Lymphocyte Count
Male
Middle Aged
Muscle, Skeletal
/ physiology
Nephroureterectomy
/ adverse effects
Neutrophils
/ pathology
Nutrition Assessment
Platelet Count
Postoperative Complications
/ etiology
Preoperative Period
Prognosis
Urologic Neoplasms
/ drug therapy
Inflammation
Nephroureterectomy
Nutrition
Preoperative prognostic factor
Sarcopenia
Upper urinary tract urothelial carcinoma
Journal
International journal of clinical oncology
ISSN: 1437-7772
Titre abrégé: Int J Clin Oncol
Pays: Japan
ID NLM: 9616295
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
03
08
2018
accepted:
13
12
2018
pubmed:
4
1
2019
medline:
11
7
2019
entrez:
4
1
2019
Statut:
ppublish
Résumé
The present study evaluated the clinical relevance of an integrative preoperative assessment of inflammation-, nutrition-, and muscle-based markers for patients with upper urinary tract urothelial carcinoma (UTUC) undergoing curative nephroureterectomy (NUx). The study enrolled 125 patients and the preoperative variables assessed included age, body mass index, neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), serum fibrinogen level (Fib), C-reactive protein (CRP), modified Glasgow prognostic score, serum albumin level (Alb), prognostic nutritional index (PNI), skeletal muscle index (SMI), psoas muscle index (PMI), and peak expiratory flow (PEF). The correlations among the variables and their prognostic values after NUx were evaluated. Five inflammation markers (NLR, MLR, PLR, Fib and CRP) were positively correlated. Fib was positively correlated with NLR, PLR and CRP, but inversely correlated with SMI. PNI was inversely correlated with age and the four inflammation markers (p < 0.001). Age was not significantly correlated with the inflammation markers, but older age was associated with lower Alb, PNI, SMI, PMI, and PEF. Disease-specific survival was independently predicted by preoperative ipsilateral hydronephrosis and low PNI. Overall survival was independently associated with high Fib and low PNI. The preoperative inflammation-, nutrition-, and muscle-based markers would be useful risk assessment tools for UTUC.
Identifiants
pubmed: 30604161
doi: 10.1007/s10147-018-01381-y
pii: 10.1007/s10147-018-01381-y
doi:
Substances chimiques
Biomarkers
0
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
533-545Références
Acta Med Scand. 1963 Feb;173:185-92
pubmed: 13970718
J Appl Physiol (1985). 2004 Dec;97(6):2333-8
pubmed: 15310748
Blood. 2005 Jan 1;105(1):178-85
pubmed: 15367435
Am J Clin Nutr. 2006 Jun;83(6):1345-50
pubmed: 16762946
Urol Oncol. 2011 Jan-Feb;29(1):27-32
pubmed: 19117771
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Eur Urol. 2012 Jul;62(1):100-14
pubmed: 22381168
BJU Int. 2013 May;111(6):857-64
pubmed: 22757942
Clin Nutr Res. 2013 Jan;2(1):12-8
pubmed: 23431114
J Clin Oncol. 2013 Apr 20;31(12):1539-47
pubmed: 23530101
Can Urol Assoc J. 2013 Mar-Apr;7(3-4):E215-20
pubmed: 23671529
World J Surg. 2013 Nov;37(11):2688-92
pubmed: 23884382
BJU Int. 2014 May;113(5b):E144-9
pubmed: 24274691
J Urol. 2014 Apr;191(4):920-5
pubmed: 24513163
Int Braz J Urol. 2014 Nov-Dec;40(6):753-62
pubmed: 25615244
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
World J Surg. 2015 Jun;39(6):1501-9
pubmed: 25670038
Ann Surg Oncol. 2016 Jan;23(1):321-7
pubmed: 26045392
Gynecol Oncol. 2015 Sep;138(3):560-5
pubmed: 26163893
Eur Urol. 2015 Nov;68(5):868-79
pubmed: 26188393
PLoS One. 2015 Sep 10;10(9):e0136897
pubmed: 26356222
Oncol Lett. 2015 Nov;10(5):3113-3122
pubmed: 26722298
BJU Int. 2016 Oct;118(4):598-603
pubmed: 26780664
Urol Oncol. 2016 Jun;34(6):257.e11-7
pubmed: 27038696
Nutrition. 2016 Nov-Dec;32(11-12):1200-5
pubmed: 27292773
Cancer Med. 2016 Sep;5(9):2213-20
pubmed: 27350148
Jpn J Clin Oncol. 2016 Dec;46(12):1148-1155
pubmed: 27576438
Oncotarget. 2017 Mar 21;8(12):18792-18801
pubmed: 27852046
Ann Surg. 2018 Mar;267(3):527-531
pubmed: 27984214
BMC Cancer. 2017 Mar 31;17(1):237
pubmed: 28359307
Oncology. 2017;93(4):259-269
pubmed: 28647740
Oncotarget. 2017 Mar 22;8(40):68964-68973
pubmed: 28978171
Annu Rev Med. 1986;37:179-86
pubmed: 3010804
Transl Androl Urol. 2018 Dec;7(6):984-986
pubmed: 30505738
Nihon Geka Gakkai Zasshi. 1984 Sep;85(9):1001-5
pubmed: 6438478